French Validation of the Brief Negative Symptom Scale (BNSS)
The Canadian Journal of Psychiatry · 2025
DOI: 10.1177/07067437251328350 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Canadian Journal of Psychiatry, 2025. Verfasst von Lucie Métivier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Normandie Univ, UNICAEN, PhIND, UMR-S 1237, Caen, France. Hauptthemen laut MEDLINE: Psychometrics, Schizophrenia, Psychotic Disorders, Psychiatric Status Rating Scales. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: RHU Psycare.
Abstract (Originalsprache)
Objectives
This study aims to validate the French version of the Brief Negative Symptom Scale (BNSS) by assessing its psychometric properties in a population of patients with schizophrenia or schizoaffective disorder.
Methods
73 patients with schizophrenia or schizoaffective disorder were included. Participants were evaluated using the BNSS, the Positive and Negative Syndrome Scale (PANSS), and the Self-Evaluation of Negative Symptoms (SNS). The internal consistency of the BNSS was measured using Cronbach's alpha, structural validity was assessed through exploratory factor analysis, and construct validity was evaluated with Spearman correlations between BNSS scores, the negative subscale of the PANSS, the total SNS score, the positive subscale of the PANSS, and PANSS items evaluating insight and depressive mood.
Results
The internal consistency of the BNSS was excellent (Cronbach's alpha = 0.93). Exploratory factor analysis revealed two factors corresponding to the motivational and expressive dimensions of negative symptoms. Significant positive correlations were found between total BNSS scores and the negative subscale of the PANSS (Rho = 0.77; p < 0.001), as well as with SNS scores (Rho = 0.55; p < 0.001). No correlation was observed between total BNSS scores and the positive subscales of the PANSS (Rho = 0.09; p = 0.41). However, significant positive correlations were noted with the PANSS item assessing depression (Rho = 0.28; p = 0.015) and insight (Rho = 0.43; p < 0.001).
Conclusion
The French version of the BNSS has demonstrated strong psychometric properties and is suitable for clinical and research use. Plain Language Summary Title Validation d’une échelle d’évaluation des symptômes négatifs, la « Brief Negative Symptom Scale » (BNSS)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Normandie Univ, UNICAEN, PhIND, UMR-S 1237, Caen, France.
- Normandie Univ, UNICAEN, Fédération Hospitalo-Universitaire (FHU A2M2P), Caen, France.
- CHU de CAEN Normandie, Service de Psychiatrie, Centre Esquirol, Caen, France.
- Centre Hospitalier du Rouvray, Service Hospitalo-Universitaire de Psychiatrie, Centre Thérapeutique d'Excellence, Sotteville-lès-Rouen, France.
- Normandie Univ, UNICAEN, UFR Médecine, Caen, France.
ORCID-Profile: Lucie Métivier, Sonia Dollfus
Förderung
- RHU Psycare
Zitieren
APA
Métivier, L., Tréhout, M., Leroux, E., Rothärmel, M., & Dollfus, S. (2025). French Validation of the Brief Negative Symptom Scale (BNSS). The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437251328350
Vancouver
Métivier L, Tréhout M, Leroux E, Rothärmel M, Dollfus S. French Validation of the Brief Negative Symptom Scale (BNSS). The Canadian Journal of Psychiatry. 2025. doi:10.1177/07067437251328350
BibTeX
@article{Mtivier2025,
author = {Métivier, Lucie and Tréhout, Maxime and Leroux, Elise and Rothärmel, Maud and Dollfus, Sonia},
title = {French Validation of the Brief Negative Symptom Scale (BNSS)},
journal = {The Canadian Journal of Psychiatry},
year = {2025},
doi = {10.1177/07067437251328350}
}
EUVIMED